Emergent Biosolutions, Inc. (NYSE: EBS)
$10.0400
-0.2300 ( -2.90% ) 555.3K
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Market Data
Open
$10.0400
Previous close
$10.2700
Volume
555.3K
Market cap
$552.95M
Day range
$9.8960 - $10.5110
52 week range
$1.4200 - $15.1000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 17, 2024 |
| 4 | Insider transactions | 1 | Dec 10, 2024 |
| 3 | Insider transactions | 4 | Nov 21, 2024 |
| 4 | Insider transactions | 1 | Nov 14, 2024 |
| 4 | Insider transactions | 1 | Nov 13, 2024 |
| 4 | Insider transactions | 1 | Nov 13, 2024 |
| 3 | Insider transactions | 4 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 195 | Nov 07, 2024 |
| 8-k | 8K-related | 59 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Oct 17, 2024 |